A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00091520|
Recruitment Status : Completed
First Posted : October 1, 2004
Last Update Posted : May 20, 2011
|Condition or disease||Intervention/treatment||Phase|
|Heart Failure, Congestive||Drug: Nesiritide||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||920 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Follow-up Serial Infusions of Natrecor(Nesiritide) in the Management of Patients With Heart Failure-FUSION II|
|Study Start Date :||April 2004|
|Study Completion Date :||December 2006|
- Time to all-cause death or first occurrence of hospitalization for cardiovascular and/or renal causes from the day of randomization through week 12.
- Number of cardiovascular and/or renal hospital admissions adjusted for duration of observation period through the end of week 12. Days alive and out of the hospital from the day of randomization through the end of week 12.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00091520
|Study Director:||Scios, Inc. Clinical Trial||Scios, Inc.|